Biotherapeutics Companies in BioPortfolio's Corporate Database
Biotherapeutics company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Biotherapeutics companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Biotherapeutics Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Biotherapeutics Companies.
More Information about Biotherapeutics on BioPortfolio
We have published hundreds of Biotherapeutics news stories on BioPortfolio along with dozens of Biotherapeutics Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Biotherapeutics for you to read.
Showing "biotherapeutics biotherapeutic" Companies 1 to 25 of 79
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs and vaccines. Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas. Xenetic are also a...
Eleven Biotherapeutics creates novel and differentiated biotherapeutics: first-of-a-kind protein-based drugs with significantly improved physical, pharmaceutical, and therapeutic benefits. The companyâs AMP-Rx⢠product engine brings capabilities beyond conventional approaches for making protein therapeutics, opening up new territory for the produ...
Thrasos TherapeuticsTM is a private, clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company is advancing therapeutic programs, led by THR-184, for renal diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD). Thrasosâ...
APO-T is a biopharmaceutical company focused on the development and commercialization of proprietary biotherapeutics for oncology. APO-T has developed fully-human antibodies and antibody fragments that target any tumor cell that expresses a MAGE-A peptide in the context of MHC-1. Many different kinds of tumors expose this MAGE-MHC-1 peptide complex. They a...
Hepregen Corporation is the undisputed leader in innovating unique and proprietary bioengineered micro- liver platforms for use in environmental testing, preventive care, and pharmaceutical, biotherapeutic and diagnostic product development. The Companyâs âliver-in-a-dishâ HepatoPac⢠and HepatoMune⢠products support a potential par...
Dyax is a fully integrated biopharmaceutical company focused on discovering, developing and commercializing novel biotherapeutics for unmet medical needs. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development. Our lead product, DX-88, has been approved under the brand name...
Zymeworks is a privately held biotechnology company that is developing best-in-class antibody therapeutics for the treatment of oncology, autoimmunity and inflammatory diseases. The companyâs proprietary ZymeCAD⢠structure-guided protein engineering technology and its novel Azymetric⢠and AlbuCORE⢠platforms enable the development of highly...
Xencor, Inc. engineers superior biotherapeutics using its proprietary Protein Design Automation® technology platform, and is a leader in the field of antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency. The company is advancing multiple XmAb® antibody drug candidates into the clinic, including XmAb...
Xcellerex is revolutionizing the way biomolecules are developed, manufactured and commercialized. The companyâs unique single-use component technology platform transforms biomanufacturing economics, enabling the development of biotherapeutics and vaccines, and dramatically improving the ability of Xcellerex and its partners to deploy manufacturing cap...
Scarab Genomics, a Madison, Wisconsin based biotechnology company, was established in 2002 to commercialize the Clean Genome® Multiple Deletion Series (MDS) E. coli that resulted from Dr. Fred Blattnerâs first sequencing of E. coli at the University of Wisconsin. Scarab Genomics licensed the patented reduced genome technology from the Wisconsin Alu...
Bicycle Therapeutics is a biotechnology company based at the Babraham Research Campus in Cambridge, U.K. developing a novel technology for the creation of a new generation of biotherapeutics which combine the desirable features of small molecules and biopharmaceuticals. Bicycle technology is based on the work performed at the MRC Laboratory of Molecular...
Eleven Biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. Eleven Biotherapeutics' scientists are engineering protein-based drugs using newly available structural information and the companyâs unique molecul...
Juvaris BioTherapeutics is a clinical stage company developing adjuvanted vaccines to treat infectious diseases. The Companyâs lead adjuvant, JVRS-100, is a cationic lipid-DNA complex that is being developed as an adjuvant to improve the effectiveness of existing vaccines and to develop new vaccines against a variety of infectious diseases. Research...
Protalix Biotherapeutics, Inc.
Protalix is a biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins expressed through its proprietary plant cell based expression system. Protalixâs ProCellEx(TM) presents a proprietary method for the expression of recombinant proteins that Protalix believes will allow for the cost-e...
InCytu is a privately held biotherapeutic company with its primary operations located in Rhode Island. The Company is targeting its Cellarium vaccine at treating late stage melanoma tumors while gathering promising preliminary data using the Cellarium to treat other cancers. InCytu has established a manufacturing facility for creating Cellarium devices in...
Magene Life Sciences Pvt. Ltd. is a Contract Research Organisation, which provides services to improve the drug development programs by reducing the costs and accelerating the pace of pharmaceutical R&D. With our multidisciplinary approach, we provide solutions ranging from biotherapeutic process development to in vitro screening methods.Keeping in mind, people’s well - being and improvement of...
MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which breaks down the barriers to ex vivo cell loading and the manufacture of viral vectors. MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leuke...
Medicago is a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The Company is committed to providing highly effective and competitive vaccines and therapeutic proteins based on its proprietary Virus-Like Particles (VLPs) and manufacturing technologies. Medicago is a worldwide leader in the devel...
Northwest Biotherapeutics (NWBT) is a biotechnology company focused on the clinical development of autologous immunotherapy products for cancer. Our technology platform, DCVax®, uses a patient’s own dendritic cells, the starter engine of the immune system, which are loaded with tumor proteins or antigens. Injection of these cells back into the patient initiates a potent immune response against...
NEMOD Biotherapeutics GmbH & Co. KG
NEMOD Biotherapeutics GmbH & Co. KG is a biotechnology company specialized in drug discovery and development in the field of oncology. NEMOD combines its expertise in tumor immunology, antibody technology, cellular engineering, glycobiology and dendritic cell biology to develop innovative anticancer therapy approaches.NEMOD’s business activities focus on the development of own therapeutics,...
Protiva is a development stage biotechnology company, focused on pharmaceutical products to fight serious human disease. Protiva's proprietary SNALP technology enables the development of novel nucleic acid-based drugs, such as those that utilize siRNA. Protiva was founded in September of 2000 based on technology developed at The University of British Columbia.Protiva's headquarters is in Seattle,...
Talecris Biotherapeutics is a new company proud to inherit a legacy of more than 60 years of providing lifesaving and life-enhancing plasma-derived therapeutic proteins. Through the assets of Bayer Biological Products’ plasma business, Talecris’ heritage of patient care innovations in therapeutic proteins dates back to the blood-derived products Cutter Laboratories began to produce in the earl...
Tragen Pharmaceuticals (formerly Immunogenex, Inc.) is developing a family of potent biotherapeutics for the treatment of disease. At the core of Tragen's proprietary technology are recombinant forms of the tumor necrosis factor (TNF) family of molecules. Coupled with our expertise in gene delivery systems, we are creating an effective and sustainable approach for treating disease.
Viropro Inc. (“Viropro”) operates through Viropro International Inc., a Canadian company with its Head Office in Montreal. Viropro International Inc. is specialized in the technology transfer, for industrial production, of affordable biological therapeutic products (also named biogeneric products, biogenerics, biopharmaceuticals or biotherapeutics) whose licenses have expired. The principal...
Established in 1995,Vybion, Inc. , formerly Viral Therapeutics, develops and manufactures recombinant proteins, including biotherapeutics, viral antigens, cellular proteins, cytokines, growth factors, and other proteins for diagnostic, therapeutic and reagent applications. Vybion has licensed or owns over 110 patents for technology and products and has developed nearly 100 recombinant proteins for...
